HAE Financial Facts
Total operating expenses: 79.45MIncome before provision for income taxes: 22.83M
See Full Income Statement
Other long-term assets: 13.66M
Total liabilities and stockholders' equity: 1.33B
See Full Balance Sheet
Haemonetics Corp. (HAE) Earnings
|
Expand Research on HAE
| Next EPS Date | 5/9/24 | EPS Growth Rate | +15.6% |
|---|---|---|---|
| Average EPS % Beat Rate | +18.9% | Revenue Growth Rate | +8.4% |
| Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/24  |
Q424 | N/A | $0.89 | N/A | N/A | $329.47M | = | N/A | N/A | ||
| 2/8/24 | Q324 | $1.04 | $0.94 | +$0.10 | $336M | $320.77M | = |  | | Details | |
| 11/2/23 | Q224 | $0.99 | $0.89 | +$0.10 | $318.2M | $313.12M | = | | | Details | |
| 2/7/23 | Q323 | $0.85 | $0.82 | +$0.03 | $305.3M | $299.08M | = | | | Details | |
| 8/8/23 | Q124 | $1.05 | $0.73 | +$0.32 | $311.3M | $292.69M | = | | | Details | |
| 5/11/23 | Q423 | $0.77 | $0.70 | +$0.07 | $304M | $290.79M | = | | | Details | |
| 11/7/22 | Q223 | $0.83 | $0.68 | +$0.15 | $297.48M | $270.46M | = | | | Details | |
| 2/8/22 |  |
Q322 | $0.84 | $0.73 | +$0.11 | $260M | $266.94M | = | | | Details |
